Effect of a tadalafil 5-mg single daily dose on lifelong premature ejaculation: A single-blinded placebo-controlled study
- PMID: 35530567
- PMCID: PMC9067979
- DOI: 10.1080/2090598X.2021.2007464
Effect of a tadalafil 5-mg single daily dose on lifelong premature ejaculation: A single-blinded placebo-controlled study
Abstract
Objective: To investigate the effectiveness and safety of a tadalafil 5-mg single daily dose in the treatment of lifelong premature ejaculation (PE).
Patients and methods: A total of 55 men with lifelong PE were enrolled in this study. The intravaginal ejaculatory latency time (IELT) and Premature Ejaculation Diagnostic Tool (PEDT) were used to assess the efficacy of tadalafil. Baseline recording of the IELT (using a stopwatch) and PEDT was done. Patients were randomised to take a single daily dose of tadalafil 5 mg or placebo. Re-assessment was done by IELT and PEDT after 1 and 3 months.
Results: As regard, age, number of children, frequency of intercourse and duration of PE there are no statically significant differences between both groups. In both the tadalafil 5-mg and placebo groups the IELT statically significantly increased after 1 month by a mean (SD) of 4.8 (4.7) and 5 (4.9) s, and after 3 months by a mean (SD) of 6.6 (7) and 4.5 (9) s; and the PEDT scores significantly improved after 1 month by a mean (SD) of 2.1 (1.9) and 2 (1.5), and after 3 months by a mean (SD) of 3.5 (2.5) and 3.3 (2.2). However, there is was no statically significant difference between the tadalafil 5-mg and placebo groups for the IELT and PEDT at baseline or after 1 and 3 months of treatment.
Conclusions: Despite 5-mg tadalafil once daily being safe and it showed only a slight improvement in IELT and PEDT in the treatment of lifelong PE, failing to show any statistically significant difference from the placebo drug.Abbreviations: ED: erectile dysfunction; 5-HT: 5-hydroxytryptamine (serotonin); IELT: the intravaginal ejaculation latency time; ISSM: International Society of Sexual Medicine; PE: premature ejaculation; PEDT: Premature Ejaculation Diagnostic Tool; PDE5i: phosphodiesterase-5 inhibitor; SSRI: selective serotonin reuptake inhibitor.
Keywords: PDE5 inhibitors; PEDT; Premature ejaculation; lifelong premature ejaculation; tadalafil.
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
Similar articles
-
Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study.Urol Int. 2008;80(2):162-5. doi: 10.1159/000112607. Epub 2008 Mar 19. Urol Int. 2008. PMID: 18362486 Clinical Trial.
-
Short- and long-term follow-up results of daily 5-mg tadalafil as a treatment for erectile dysfunction and premature ejaculation.Arab J Urol. 2022 Jan 23;20(1):49-53. doi: 10.1080/2090598X.2021.2024695. eCollection 2022. Arab J Urol. 2022. PMID: 35223110 Free PMC article.
-
Retrospective evaluation of the efficacy of daily paroxetine/tadalafil combination in patients with premature ejaculation and erectile dysfunction.Eur Rev Med Pharmacol Sci. 2023 May;27(9):4248-4253. doi: 10.26355/eurrev_202305_32335. Eur Rev Med Pharmacol Sci. 2023. PMID: 37203851
-
An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation.Sex Med. 2014 Jun;2(2):41-59. doi: 10.1002/sm2.27. Sex Med. 2014. PMID: 25356301 Free PMC article. Review.
-
An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation.J Sex Med. 2014 Jun;11(6):1423-41. doi: 10.1111/jsm.12524. Epub 2014 May 22. J Sex Med. 2014. PMID: 24848805 Review.
Cited by
-
Pooled-analysis of tadalafil and tamsulosin for ureteral calculi.Front Pharmacol. 2024 May 30;15:1351312. doi: 10.3389/fphar.2024.1351312. eCollection 2024. Front Pharmacol. 2024. PMID: 38873423 Free PMC article.
References
-
- Rowland D, Perelman M, Althof S, et al. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med. 2004;1:225–232. - PubMed
-
- Rowland DL, Patrick DL, Rothman M, et al. The psychological burden of premature ejaculation. J Urol. 2007;177:1065–1070. - PubMed
-
- Porst H, Montorsi F, Rosen RC, et al. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007;51:816–824. - PubMed
-
- Serefoglu EC, McMahon CG, Waldinger MD, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. J Sex Med. 2014;11:1423–1441. - PubMed
-
- American Psychiatric Association . Diagnostic and statistical manual of mental disorders (DSM-5 (R)). 5th ed. Arlington (TX): American Psychiatric Association Publishing; 2013.
LinkOut - more resources
Full Text Sources
Research Materials